# Symrise, Inc, Goose Creek, SC – FDA Inspections

Source: https://www.keypedia.com/companies/symrise-inc/3c94427e-fd36-4498-bcbd-148093d778bd

> Inspection records and compliance data for Symrise, Inc in Goose Creek, South Carolina. 6 FDA inspections on record, 1 Form 483, last inspected February 28, 2025.

---

## Details

- Name: Symrise, Inc
- FEI Number: 1049679
- Address Line 1: 1636 Bushy Park Rd
- City: Goose Creek
- State: South Carolina
- Zip Code: 29445
- Country Name: United States
- Address: 1636 Bushy Park Rd, Goose Creek, South Carolina 29445, United States
- Country: United States

## Related Documents

- [483 - Symrise, Inc - 2025-02-28](https://www.keypedia.com/records/483/symrise-inc/84a265df-ee4b-4fa0-8127-f30957ada5c8) — source: FDA, date: February 28, 2025
- [FDA Inspection 1263986 - Symrise, Inc - 2025-02-28](https://www.keypedia.com/records/fda_inspections/symrise-inc/ffc69ff7-be2e-4950-9353-4f7bbd700fc5) — source: FDA, date: February 28, 2025
- [EIR - Symrise, Inc - 2019-05-23](https://www.keypedia.com/records/eir/symrise-inc/91801893-34c4-460a-a299-f5059b4fb3f9) — source: FDA, date: May 23, 2019
- FDA Inspection 1108190 - Symrise, Inc - 2019-05-23 — classification: No Action Indicated (NAI), source: FDA, date: May 23, 2019
- [483 - Symrise, Inc - 2015-08-27](https://www.keypedia.com/records/483/symrise-inc/600f6467-5fdf-4d85-b0f7-b39092da2701) — source: FDA, date: August 27, 2015
- FDA Inspection 942373 - Symrise, Inc - 2015-08-27 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 27, 2015
- [EIR - Symrise, Inc - 2012-06-06](https://www.keypedia.com/records/eir/symrise-inc/8c307dab-7588-459e-85c9-747abb416dd7) — source: FDA, date: June 6, 2012
- FDA Inspection 786352 - Symrise, Inc - 2012-06-06 — classification: No Action Indicated (NAI), source: FDA, date: June 6, 2012
- FDA Inspection 729728 - Symrise, Inc - 2011-05-27 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 27, 2011
- FDA Inspection 603571 - Symrise, Inc - 2009-07-21 — classification: No Action Indicated (NAI), source: FDA, date: July 21, 2009

## Related Companies

- [UCB Pharma S.A.](https://www.keypedia.com/companies/ucb-pharma-sa/6a03badf-6619-4125-b598-85ceebcc8c50)
- [Ava Inc](https://www.keypedia.com/companies/ava-inc/2b241090-1e53-4f25-8e52-c8105395fb0b)
- [Bajaj Medical, LLC](https://www.keypedia.com/companies/bajaj-medical-llc/3aea5c6c-9e94-429d-82a0-594d8f8c666e)
- [Sandoz GmbH](https://www.keypedia.com/companies/sandoz-gmbh/02a3eaeb-a765-43ae-873b-93d1d1523696)
- [AndersonBrecon Inc.](https://www.keypedia.com/companies/andersonbrecon-inc/799f84ea-9114-456a-83f1-7edcd7eb4d2e)
- [Chartwell Pharmaceuticals Carmel LLC](https://www.keypedia.com/companies/chartwell-pharmaceuticals-carmel-llc/7d10681a-1557-4f23-bde4-a9fad718e27f)
- [Almac Pharma Services LLC](https://www.keypedia.com/companies/almac-pharma-services-llc/a5015855-2f01-4474-895d-a397cc89e5fa)
- [Pharma Nobis LLC](https://www.keypedia.com/companies/pharma-nobis-llc/65e636d3-cd04-456d-b82a-a681bb7bdb9e)
- [Aurolife Pharma, LLC](https://www.keypedia.com/companies/aurolife-pharma-llc/b82a0c8c-6b52-4624-8c6c-21887615bc7d)
- [BioConvergence LLC](https://www.keypedia.com/companies/bioconvergence-llc/4cc83f06-5906-4f34-b2ec-8e192e598448)

## Related Officers

- [Investigator](https://www.keypedia.com/people/lareese-k-thomas/758b3873-995f-4df3-80f6-658c70f23379)
- [issuing_officer](https://www.keypedia.com/people/calvin-foulks/cf0a926f-e2e1-4305-b6c8-4bcb298847f0)
- [Shanna Pratt](https://www.keypedia.com/people/shanna-pratt/68e11983-f45b-47fa-84a8-2c0db7dfc949)
- [investigator](https://www.keypedia.com/people/lawrence-thomas/0f0863ce-7dcf-422a-867e-b8758b596fbd)
- [company_representative](https://www.keypedia.com/people/madeline-malone/26e5431f-1669-43e8-a643-13b7728c6cfa)
